SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-133914
Filing Date
2016-07-22
Accepted
2016-07-22 17:01:11
Documents
9
Period of Report
2016-07-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-15258_18k.htm 8-K 130450
2 EX-3.1 a16-15258_1ex3d1.htm EX-3.1 11506
3 EX-3.2 a16-15258_1ex3d2.htm EX-3.2 9703
4 EX-10.1 a16-15258_1ex10d1.htm EX-10.1 164777
5 EX-10.2 a16-15258_1ex10d2.htm EX-10.2 100183
6 EX-10.3 a16-15258_1ex10d3.htm EX-10.3 127809
7 EX-10.4 a16-15258_1ex10d4.htm EX-10.4 119308
8 EX-16.1 a16-15258_1ex16d1.htm EX-16.1 2720
9 EX-99.1 a16-15258_1ex99d1.htm EX-99.1 13673
  Complete submission text file 0001104659-16-133914.txt   681815
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 161780186
SIC: 2834 Pharmaceutical Preparations